insights_auto
Why is EDIT down 4,09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,64 $
arrow_downward
-4,09%(-0,070) 1D
1,66 $
arrow_upward
+1,22% (+0,020)bedtimeAfter hours
Closed: 20 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,69 $
High
1,78 $
Low
1,63 $
Mkt. cap
253,12 մլն
Avg. vol.
2,24 մլն
Volume
2,68 մլն
52-wk high
3,94 $
52-wk low
1,63 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,69 $
High
1,78 $
Low
1,63 $
Mkt. cap
253,12 մլն
Avg. vol.
2,24 մլն
Volume
2,68 մլն
52-wk high
3,94 $
52-wk low
1,63 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
BeInCrypto
·
9 ժամ առաջ
China, Korea and Taiwan Rush Stock Rescues Before Monday: Can They Help the S&P 500?
Bloomberg.com
·
2 ժամ առաջ
S&P 500 at 5,600? Crushing China’s AI Ambitions Has a Price
Crypto Briefing
·
4 ժամ առաջ
Nasdaq slides deeper as Nvidia rout drags S&P 500 and Dow into correction
cwibc.co.id
·
1 ժամ առաջ
S&P 500 Faces Thanksgiving Week After Sharp Market Selloff
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc